Publication | Closed Access

Addition of second-line steroid sparing immunosuppressants like mycophenolate mofetil improves outcome of Immunoglobulin G4-related disease (IgG4-RD): a series from a tertiary care teaching hospital in South India

Mycophenolate MofetilAutoimmune DiseaseImmunosuppressive TherapyImmunodeficienciesImmunologyClinical TrialsAutoimmunityImmunologic DiseaseImmunosuppressionSouth IndiaImmunotherapyMedicineImmunoglobulin G4-related Disease